LumiraDx Limited Warrant
LMDXW
LMDXW was delisted on the 8th of January, 2024.
15 hedge funds and large institutions have $344K invested in LumiraDx Limited Warrant in 2023 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 2 closing their positions.
0% more funds holding
Funds holding: 15 → 15 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
75% less capital invested
Capital invested by funds: $1.35M → $344K (-$1.01M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$3.19K |
| 2 |
CAM
Cresset Asset Management
Chicago,
Illinois
|
+$400 |
| 3 |
Morgan Stanley
New York
|
+$55 |
| 4 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$36 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Senvest Management
New York
|
-$60.1K |
| 2 |
MCM
Moore Capital Management
New York
|
-$1.81K |
LMDXW Hedge Fund Activity: Q4 2023 in Review
15 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in LumiraDx Limited Warrant (LMDXW) for Q4 2023, worth a combined $344K — down 75% from $1.35M a quarter earlier.
Fund positioning in LMDXW was balanced in Q4 2023: 2 funds opened new positions, 2 closed out, 2 added to existing stakes and 0 trimmed.
The largest buyer was Goldman Sachs, opening a new position worth an estimated $3.19K. The largest seller was Senvest Management, exiting entirely with an estimated $60.1K sold.
- 15 institutional investors held LumiraDx Limited Warrant (LMDXW) as of Q4 2023, unchanged from Q3 2023.
- Funds reported $344K of LumiraDx Limited Warrant stock for Q4 2023, down 75% quarter-over-quarter.
- 2 funds opened new LumiraDx Limited Warrant positions in Q4 2023 and 2 closed out, a net change of 0 holders.
- The largest LumiraDx Limited Warrant buyer in Q4 2023 was Goldman Sachs, an estimated $3.19K added.
- The largest LumiraDx Limited Warrant seller in Q4 2023 was Senvest Management, an estimated $60.1K sold.
Based on aggregated 13F filings for Q4 2023.